Temple
Temple is moving toward launch, with pre-orders expected to open next week at an expected ₹75,000 to ₹1 lakh and the first 100 units ready to ship (Digit, 10 Oct). Shipments are still unconfirmed for India, and no India launch date is set (Business Today, 26 Sept).
What it means Wearable rivals face a premium entrant backed by clinical validation, including a 60-participant study and the Longevous acquisition.
Latest moves
Our read of each move first, where we have one; what the report said is marked Reported.
Background
From 9 stories, the newest dated 3 Oct 2026. Summary written 3 Oct 2026. Newer developments are under Latest moves.
Temple is a healthtech wearable startup backed by Deepinder Goyal, who moved from Eternal group CEO to vice chairman in February 2026 to pursue ventures outside food, including Temple.[1] source: Medianama[2] source: Business Today
Show 3 more paragraphs and 9 sources
It was founded in 2024.[3] source: YourStory Its wearable, BrainFlow, is designed to monitor brain blood flow.[4] source: NDTV Profit[5] source: NDTV Profit Inc42 reported that Temple is funded at ₹493 Cr, with a valuation of about ₹1,700 Cr or $204 Mn.[6] source: Inc42
In September 2026 Temple published a preprint validation study for BrainFlow ahead of an India launch, reporting a BrainFlow-brain signal correlation of 0.912 against 0.494 for the BrainFlow-scalp signal.[7] source: Business Today On October 1, 2026 Goyal revealed six launch colours, three standard and three limited-edition, with pre-orders expected to open the following week.[8] source: ET Retail[4] source: NDTV Profit Shipping of the limited launch edition is targeted before the end of 2026, and waitlist users get priority.[8] source: ET Retail The Economic Times earlier reported a price of Rs 75,000-80,000, while NDTV Profit said the price was undisclosed.[8] source: ET Retail[4] source: NDTV Profit In August 2026 Temple acquired London longevity clinic Longevous for undisclosed terms.[1] source: Medianama[9] source: NDTV Profit
Longevous founders Robert Mohr and Avi Roy are joining Temple as chief medical officer and head of science.[1] source: Medianama In September 2026 Temple partnered with the research arm of Art of Living to study meditation using its Entropy biomarker.[3] source: YourStory
Sources
Questions about Temple
What is Temple's current strategy in India?
Temple acquired London clinic Longevous in August 2026, partnered with Art of Living's research arm in September 2026, and published BrainFlow validation research in September 2026. In October 2026 it revealed six launch colours, with pre-orders expected the following week.[8] source: ET Retail[3] source: YourStory[1] source: Medianama[9] source: NDTV Profit
More stories about Temple
- Temple acquires London longevity practice Longevous ahead of wearable launch
- Deepinder Goyal’s Temple shrinks wearable for limited preorder launch
- PV Sindhu spotlights Temple’s AI brain-monitoring wearable
- Temple reaches $375m valuation in secondary sale, launches ESOP liquidity plan
Stories that mention Temple
2 stories
Temple is named in these stories but is not their subject.